The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
GLP-1 weight loss drugs are reshaping more than waistlines—they're lightening airplane loads to cut fuel costs and dimming alcohol's appeal for millions. This butterfly effect reveals the profound behavioral shifts these medications induce. Learn the science and real-world implications.
Oprah Winfrey shared on her podcast that stopping GLP-1 injections led to significant weight regain, sparking debate on obesity treatment. Expert insights reveal these drugs treat a chronic condition, not just temporary weight loss. Learn the science, risks, and how to approach long-term success.
Move over protein—fiber is surging as the must-have nutrient for gut health and natural appetite control via GLP-1. With Gen Z leading the 'fibermaxxing' trend on TikTok, food giants are responding, but experts urge whole foods over processed snacks. This guide explains the science, ties to GLP-1 meds, and practical tips for better metabolic health.
GLP-1 medications like Ozempic and Mounjaro aren't just shedding pounds—they're slimming down grocery bills, restaurant tabs, and alcohol sales while boosting fitness and fashion spending. With 2.5 million UK users and rising, businesses are adapting fast. Learn the science behind these shifts and how to navigate them effectively.
The chilling film 'Saccharine' imagines a diet pill worse than Ozempic—made from human ashes. But what does it reveal about real GLP-1 weight loss drugs? This guide dives into the science, psychological pitfalls, and evidence-based tips for safe use.
At 400lbs, Devyn McGuire hit rock bottom, but two simple changes—walking and calorie control—sparked a 200lb transformation without Ozempic or Wegovy. His story proves natural methods can rival medications when backed by science and consistency. Learn the strategies, mechanisms, and mindset for your own success.
The NHS has approved a triple-strength 7.2mg Wegovy dose, promising greater weight loss for those plateauing on standard semaglutide. One user's story highlights the frustration of switching from Mounjaro due to costs, sparking debate on higher GLP-1 doses. Discover the science, safety, and what it means for metabolic health.
Novo Nordisk and Eli Lilly dominate the GLP-1 market with powerhouse drugs like Wegovy and Zepbound. But which offers better weight loss results, tolerability, and future potential? This guide breaks down the science, clinical trials, and real-world factors to help you decide.
GLP-1 injections like Ozempic, Wegovy, and Mounjaro have exploded from niche diabetes therapies to cultural icons in weight management. While offering profound metabolic benefits, their rapid mainstreaming raises questions about proper use, side effects, and societal pressures. This guide unpacks the science, real-world stories, and future implications.
